Most cited papers from Hôpital de Jolimont

Hôpital de Jolimont

What are the most cited papers from Hôpital de Jolimont?

The most cited paper from Hôpital de Jolimont is "Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society" (Børge Grønne Nordestgaard et al., 2013), with 2,797 citations. Next come "Lipoprotein(a) as a cardiovascular risk factor: current status" (1,824) and "Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management" (1,241).

Published TypeFieldAccessCitations

Showing 50 of 58 papers. Every paper with more than 132 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society Børge Grønne Nordestgaard et al. · European Heart Journal Open access	15 Aug 2013	2,797
2	Lipoprotein(a) as a cardiovascular risk factor: current status Børge Grønne Nordestgaard, M. John Chapman, Kausik Kumar Ray et al. · European Heart Journal Open access	21 Oct 2010	1,824
3	Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management M. John Chapman, Henry N. Ginsberg, Pierre Amarenco et al. · European Heart Journal Open access	29 Apr 2011	1,241
4	Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment Albert Wiegman et al. · European Heart Journal Open access	25 May 2015	898
5	Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine Børge Grønne Nordestgaard et al. · European Heart Journal Open access	26 Apr 2016	864
6	Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by geneMAGE-3 and presented by HLA-A1 Marie Marchand et al. · International Journal of Cancer	18 Jan 1999	788
7	The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management Robert Alexander Hegele et al. · The Lancet Diabetes & Endocrinology Open access	22 Dec 2013	643
8	Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study Philippa J. Talmud, Sonia H Shah, Ros Whittall et al. · The Lancet Open access	22 Feb 2013	590
9	Efficacy and Safety of Tumor Necrosis Factor Antagonists in Crohn's Disease: Meta-Analysis of Placebo-Controlled Trials Laurent Peyrin‐Biroulet, Pierre Deltenre, Nicolas de Suray et al. · Clinical Gastroenterology and Hepatology ReviewOpen access	Jun 2008	580
10	A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis Stephan Buch et al. · Nature Genetics Open access	19 Oct 2015	574
11	Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease Helena Gylling et al. · Atherosclerosis Open access	23 Nov 2013	527
12	Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy Olivier Gléhen, François Noël Gilly, Florent Boutitie et al. · Cancer Open access	24 Aug 2010	523
13	Peritoneal Carcinomatosis from Gastric Cancer: A Multi-Institutional Study of 159 Patients Treated by Cytoreductive Surgery Combined with Perioperative Intraperitoneal Chemotherapy Olivier Gléhen, François Noël Gilly, Catherine Arvieux et al. · Annals of Surgical Oncology	24 Mar 2010	492
14	Clinical and biologic features of CD4+CD56+ malignancies Jean Feuillard · Blood Open access	Mar 2002	427
15	Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: A randomized trial comparing 3- and 6-month periodicities Jean–Claude Trinchet, Cendrine Chaffaut, Valérie Bourcier et al. · Hepatology Open access	Dec 2010	400
16	Non-peptide arginine-vasopressin antagonists: the vaptans Guy Decaux, Alain Soupart, Gilbert Vassart · The Lancet	May 2008	377
17	Laparoscopic Liver Resection for Malignant Liver Tumors Jean‐François Gigot, David Glineur, Juan Santiago Azagra et al. · Annals of Surgery Open access	Jul 2002	375
18	Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome–positive ALL Philippe H. Rousselot et al. · Blood Open access	28 Apr 2016	329
19	Hypoxic Hepatitis Jean Henrion, Michaël Schapira, Raymond Luwaert et al. · Medicine	Nov 2003	326
20	Pancreaticojejunostomy versus pancreaticogastrostomy reconstruction after pancreaticoduodenectomy for pancreatic or periampullary tumours: a multicentre randomised trial Baki Topal, Steffen Fieuws, Raymond Aerts et al. · The Lancet Oncology	May 2013	298
21	Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel Arrigo F.G. Cicero et al. · Nutrition Reviews	3 Aug 2017	293
22	HLA association of amoxicillin-clavulanate–induced hepatitis Marc Leopold Hautekeete, Yves Horsmans, C. Van Waeyenberge et al. · Gastroenterology Open access	Nov 1999	287
23	Expression of MAGE genes in primary and metastatic cutaneous melanoma Francis Brasseur et al. · International Journal of Cancer	3 Nov 1995	287
24	The Role of Nutraceuticals in Statin Intolerant Patients Maciej Banach et al. · Journal of the American College of Cardiology Open access	25 Jun 2018	273
25	Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM Michel R. Langlois et al. · Clinical Chemistry Open access	14 May 2018	263
26	Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia Representatives of the Global Familial Hypercholesterolemia Community et al. · JAMA Cardiology Open access	2 Jan 2020	260
27	Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial Emmanuelle Tavernier, JM Boiron, Françoise Huguet et al. · Leukemia	5 Jul 2007	260
28	Laparoscopic liver resection of benign liver tumors B Descottes et al. · Surgical Endoscopy	2003	256
29	Pseudomyxoma peritonei: A French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy D. Élias, François Noël Gilly, F. Quénet et al. · European Journal of Surgical Oncology Open access	15 Mar 2010	249
30	Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) Antonio J. Vallejo‐Vaz et al. · Atherosclerosis Open access	28 Sep 2018	242
31	Azathioprine and 6-Mercaptopurine for the Prevention of Postoperative Recurrence in Crohn's Disease: A Meta-Analysis Laurent Peyrin‐Biroulet, Pierre Deltenre, Sandro Ardizzone et al. · The American Journal of Gastroenterology Review	30 Jun 2009	238
32	Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta-analysis of individual participant data Eric Trépo et al. · Hepatology ReviewOpen access	11 Oct 2013	233
33	Cytogenetic responses in high-risk myelodysplastic syndrome following low-dose treatment with the DNA methylation inhibitor 5-aza-2'-deoxycytidine Michael Lübbert, Pierre W. Wijermans, Regina Kunzmann et al. · British Journal of Haematology	Aug 2001	225
34	Diversity and Prevalence of Somatic Mutations in the Thyrotropin Receptor and Gsα Genes as a Cause of Toxic Thyroid Adenomas1 Jasmine Parma, Laurence Duprez, Jacqueline Van Sande et al. · The Journal of Clinical Endocrinology & Metabolism Open access	Aug 1997	224
35	Ketamine and Peripheral Inflammation Marc De Kock, Sébastien Loix, Patricia M. Lavand'homme · CNS Neuroscience & Therapeutics Open access	10 Apr 2013	223
36	Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM Michel R. Langlois et al. · Clinical Chemistry and Laboratory Medicine (CCLM) Open access	19 Dec 2019	212
37	Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia Raul Dias Santos, Andrea Ruzza, G. Kees Hovingh et al. · New England Journal of Medicine Open access	29 Aug 2020	198
38	Familial hypercholesterolaemia: A global call to arms Antonio J. Vallejo‐Vaz et al. · Atherosclerosis Open access	18 Sep 2015	180
39	Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II study Raphaël Maréchal, Bertrand Vos, Marc Polus et al. · Annals of Oncology Open access	30 Oct 2011	178
40	The anti-inflammatory effects of ketamine: state of the art. Sébastien Loix, Marc De Kock, P Henin · PubMed	2011	174
41	Survival among children and adults with sickle cell disease in Belgium: Benefit from hydroxyurea treatment Phu-Quoc Lê, Béatrice Gulbis, Laurence Dedeken et al. · Pediatric Blood & Cancer Open access	14 Jul 2015	170
42	Intensive Enteral Nutrition Is Ineffective for Patients With Severe Alcoholic Hepatitis Treated With Corticosteroids Christophe Moreno et al. · Gastroenterology Open access	4 Jan 2016	167
43	Distal Versus Conventional Radial Access for Coronary Angiography and Intervention Adel Aminian et al. · JACC: Cardiovascular Interventions Open access	17 May 2022	154
44	Common polymorphism in the PNPLA3/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease Eric Trépo, Thierry Gustot, Delphine Degré et al. · Journal of Hepatology	19 Feb 2011	151
45	Efficacy and safety of lenalidomide in intermediate-2 or high-risk myelodysplastic syndromes with 5q deletion: results of a phase 2 study Lionel Adès, Simone Boehrer, Thomas Prébet et al. · Blood Open access	5 Nov 2008	151
46	Long-Term Follow-Up of the Imatinib GRAAPH-2003 Study in Newly Diagnosed Patients with De Novo Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A GRAALL Study Aline Schmidt, Philippe H. Rousselot, Yves Chalandon et al. · Transplantation and Cellular Therapy Open access	6 Sep 2012	150
47	Management of familial hypercholesterolemia in children and young adults: Consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization Olivier S Descamps et al. · Atherosclerosis Open access	26 Jun 2011	149
48	Juvenile hemochromatosis associated with pathogenic mutations of adult hemochromatosis genes Antonello Pietrangelo, Angela Caleffi, Jean Henrion et al. · Gastroenterology Open access	Feb 2005	147
49	Serologic microbial associated markers can predict Crohn's disease behaviour years before disease diagnosis Rok Seon Choung, Fred Princen, Thomas P. Stockfisch et al. · Alimentary Pharmacology & Therapeutics	27 Apr 2016	145
50	Constitutive activation of the TSH receptor by spontaneous mutations affecting the N‐terminal extracellular domain Laurence Duprez, Jasmine Parma, Sabine Costagliola et al. · FEBS Letters Open access	16 Jun 1997	139

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.